A daily, low-dose aspirin regimen has been linked to a host of health benefits- including reduced risk of stroke, heart attack and other cardiovascular issues- but a new study has shown a surprising link between a daily aspirin regimen and reduced risk of lung cancer in women.
Of course, an aspirin regimen is not right for everyone, and daily aspirin use is not without risk. Docs cite stomach irritation, increased risk of bleeding and ulcers as possible side effects of regular aspirin use- but the findings regarding aspirin and lung cancer are still compelling.
The study involved more than 1,200 Asian women and was carried out at the National University of Singapore. Three hundred ninety-eight Chinese women diagnosed with lung cancer and 814 who had never received a diagnosis of lung cancer were included, and the study noted that those who used aspirin frequently and in the long-term (at least twice a week for a month or more) were 50% less likely to have lung cancer.
Dr. Wei-Yen Lim led the study, and in an email to Reuters, Lim explained that the findings weren’t necessarily conclusive, and the full breadth of the impact of an aspirin regimen needs to be explored before a blanket recommendation could be made.
“The question about whether aspirin use protects against lung cancer is still open to considerable debate at this point, and the published evidence to date is not conclusive.”
The study also notes that the likelihood of developing lung cancer was 62% lower among smokers in the study. The research was published in the journal Lung Cancer.